The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
AgRP(83-132) Acts as an Inverse Agonist on the Human-Melanocortin-4 Receptor
Open accessAbstract
The central melanocortin (MC) system has been demonstrated to act downstream of leptin in the regulation of body weight. The system comprises alpha-MSH, which acts as agonist, and agouti-related protein (AgRP), which acts as antagonist at the MC3 and MC4 receptors (MC3R and MC4R). This property suggests that MCR activity is tightly regulated and that opposing signals are integrated at the receptor level. We here propose another level of regulation within the melanocortin system by showing that the human (h) MC4R displays constitutive activity in vitro as assayed by adenylyl cyclase (AC) activity. Furthermore, human AgRP(83-132) acts as an inverse agonist for the hMC4R since it was able to suppress constitutive activity of the hMC4R both in intact B16/G4F melanoma cells and membrane preparations. The effect of AgRP(83-132) on the hMC4R was blocked by the MC4R ligand SHU9119. Also the hMC3R and the mouse(m)MC5R were shown to be constitutively active. AgRP(83-132) acted as an inverse agonist on the hMC3R but not on the mMC5R. Thus, AgRP is able to regulate MCR activity independently of alpha-MSH. These findings form a basis to further investigate the relevance of constitutive activity of the MC4R and of inverse agonism of AgRP for the regulation of body weight.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030 · cited 3×
“Several lines of evidence suggest that activation of central MCR inhibits food intake (1, 3).”
BackgroundRole of melanocortinergic neurons in feeding and the agouti obesity syndrome
Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J., & Cone, R. D. (1997) · Nature · doi:10.1038/385165a0 · Cited by 1,902
Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
Ollmann, M. M., Wilson, B. D., Yang, Y.-K., Kerns, J. A., Chen, Y., Gantz, I., & Barsh, G. S. (1997) · Science · doi:10.1126/science.278.5335.135 · Cited by 1,881
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons
Hahn, T. M., Breininger, J. F., Baskin, D. G., & Schwartz, M. W. (1998) · Nature Neuroscience · doi:10.1038/1082 · Cited by 1,164
A frameshift mutation in MC4R associated with dominantly inherited human obesity
Yeo, G. S. H., Farooqi, I. S., Aminian, S., Halsall, D. J., Stanhope, R. G., & O'Rahilly, S. (1998) · Nature Genetics · doi:10.1038/2404 · Cited by 1,159
A frameshift mutation in human MC4R is associated with a dominant form of obesity
Vaisse, C., Clement, K., Guy-Grand, B., & Froguel, P. (1998) · Nature Genetics · doi:10.1038/2407 · Cited by 1,100
Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor
Lu, D., Willard, D., Patel, I. R., Kadwell, S., Overton, L., Kost, T., Luther, M., Chen, W., Woychik, R. P., Wilkison, W. O., et al. (1994) · Nature · doi:10.1038/371799a0 · Cited by 1,076
Leptin Increases Hypothalamic Pro-opiomelanocortin mRNA Expression in the Rostral Arcuate Nucleus
Schwartz, M. W., Seeley, R. J., Woods, S. C., Weigle, D. S., Campfield, L. A., Burn, P., & Baskin, D. G. (1997) · Diabetes · doi:10.2337/diab.46.12.2119 · Cited by 879
Molecular cloning, expression, and gene localization of a fourth melanocortin receptor
Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S. J., DelValle, J., & Yamada, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82452-8 · Cited by 845
Molecular characterization of the mouse agouti locus
Bultman, S. J., Michaud, E. J., & Woychik, R. P. (1992) · Cell · doi:10.1016/s0092-8674(05)80067-4 · Cited by 801
Molecular cloning of a novel melanocortin receptor.
Gantz, I., Konda, Y., Tashiro, T., Shimoto, Y., Miwa, H., Munzert, G., Watson, S. J., DelValle, J., & Yamada, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53088-x · Cited by 679
Shutter, J. R., Graham, M., Kinsey, A. C., Scully, S., Lüthy, R., & Stark, K. L. (1997) · Genes & Development · doi:10.1101/gad.11.5.593 · Cited by 670
Rossi, M., Kim, M. S., Morgan, D. G. A., Small, C. J., Edwards, C. M. B., Sunter, D., Abusnana, S., Goldstone, A. P., Russell, S. H., Stanley, S. A., et al. (1998) · Endocrinology · doi:10.1210/endo.139.10.6332 · Cited by 576 · cited 2×
“Considerable evidence exists suggesting that AgRP is involved in body weight regulation (11, 12, 23, 24 ) by acting downstream of the adipose tissue-derived satiety factor leptin (25, 26).”
BackgroundResponse of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides
Marsh, D. J., Hollopeter, G., Huszar, D., Laufer, R., Yagaloff, K. A., Fisher, S. L., Burn, P., & Palmiter, R. D. (1999) · Nature Genetics · doi:10.1038/5070 · Cited by 542
Mizuno, T. M., Kleopoulos, S. P., Bergen, H. T., Roberts, J. L., Priest, C. A., & Mobbs, C. V. (1998) · Diabetes · doi:10.2337/diab.47.2.294 · Cited by 521
Salomon, Y. (1979) · PubMed · Cited by 476
Miller, M. W., Duhl, D. M., Vrieling, H., Cordes, S. P., Ollmann, M. M., Winkes, B. M., & Barsh, G. S. (1993) · Genes & Development · doi:10.1101/gad.7.3.454 · Cited by 431
Bagnol, D., Lu, X.-Y., Kaelin, C. B., Day, H. E. W., Ollmann, M., Gantz, I., Akil, H., Barsh, G. S., & Watson, S. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-j0004.1999 · Cited by 425
Mizuno, T. M. (1999) · Endocrinology · doi:10.1210/en.140.2.814 · Cited by 400
The Actin Cytoskeleton Is Required for Receptor-mediated Endocytosis in Mammalian Cells
Lamaze, C., Fujimoto, L. M., Yin, H. L., & Schmid, S. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20332 · Cited by 394
Overexpression of Agrt leads to obesity in transgenic mice
Graham, M., Shutter, J. R., Sarmiento, U., Sarosi, L., & Stark, K. L. (1997) · Nature Genetics · doi:10.1038/ng1197-273 · Cited by 387
Hrubu, V. J., Lu, D., Sharma, S. D., de L. Castrucci, A., Kesterson, R. A., Al-Obeidi, F. A., Hadley, M. E., & Cone, R. D. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00018a005 · Cited by 348
Molecular Cloning, Expression, and Characterization of a Fifth Melanocortin Receptor
Gantz, I., Shimoto, Y., Konda, Y., Miwa, H., Dickinson, C. J., & Yamada, T. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1580 · Cited by 301
Inverse agonism: pharmacological curiosity or potential therapeutic strategy?
Milligan, G., Bond, R. A., & Lee, M. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88963-4 · Cited by 287
Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo
Ollmann, M. M., Lamoreux, M. L., Wilson, B. D., & Barsh, G. S. (1998) · Genes & Development · doi:10.1101/gad.12.3.316 · Cited by 226
ART (Protein Product of Agouti-Related Transcript) as an Antagonist of MC-3 and MC-4 Receptors
Fong, T. M., Mao, C., MacNeil, T., Kalyani, R., Smith, T., Weinberg, D., Tota, M. R., & Van der Ploeg, L. H. T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7200 · Cited by 218
Physiological and Anatomical Circuitry between Agouti-Related Protein and Leptin Signaling
Wilson, B. D., Bagnol, D., Kaelin, C. B., Ollmann, M. M., Gantz, I., Watson, S. J., & Barsh, G. S. (1999) · Endocrinology · doi:10.1210/en.140.5.2387 · Cited by 206
Characterization of Agouti-Related Protein Binding to Melanocortin Receptors
Yang, Y.-K. (1999) · Molecular Endocrinology · doi:10.1210/me.13.1.148 · Cited by 189
Suzuki, I., Tada, A., Ollmann, M. M., Barsh, G. S., Im, S., Lynn Lamoreux, M., Hearing, V. J., Nordlund, J. J., & Abdel-Malek, Z. A. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12292572 · Cited by 184
Ebihara, K., Ogawa, Y., Katsuura, G., Numata, Y., Masuzaki, H., Satoh, N., Tamaki, M., Yoshioka, T., Hayase, M., Matsuoka, N., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.10.2028 · Cited by 177
Sina, M., Hinney, A., Ziegler, A., Neupert, T., Mayer, H. G., Siegfried, W., Blum, W. F., Remschmidt, H., & Hebebrand, J. (1999) · The American Journal of Human Genetics · doi:10.1086/302660 · Cited by 152
Modulation of murine melanocyte function in vitro by agouti signal protein
Sakai, C., Ollmann, M. M., Kobayashi, T., ABDEL‐MALEK, Z. A., Müller, J., Vieira, W. D., Imokawa, G., Barsh, G. S., & Hearing, V. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.12.3544 · Cited by 99
Siegrist, W., Drozdz, R., Cotti, R., Willard, D. H., Wilkison, W. O., & Eberlé, A. N. (1997) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899709036595 · Cited by 86
Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist
Skúladóttir, G. V., Jónsson, L., Skarphedinsson, J. O., Mutulis, F., Muceniece, R., Raine, A., Mutule, I., Helgason, J., Prūsis, P., Wikberg, J. E. S., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702264 · Cited by 81
Quillan, J. M., Sadée, W., Wei, E. T., et al. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00487-6 · Cited by 74
The role of agouti-related protein in regulating body weight
Wilson, B. D., Ollmann, M. M., & Barsh, G. S. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01471-9 · Cited by 73
Furumura, M., Sakai, C., ABDEL‐MALEK, Z. A., Barsh, G. S., & Hearing, V. J. (1996) · Pigment Cell Research · doi:10.1111/j.1600-0749.1996.tb00109.x · Cited by 64
Oosterom, J., Nijenhuis, W. A. J., Schaaper, W. M. M., Slootstra, J. W., Meloen, R. H., Gispen, W. H., Burbach, J. P. H., & Adan, R. A. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16853 · Cited by 60
Self-citationRosenfeld, R. D., Zeni, L., Welcher, A. A., et al. (1998) · Biochemistry · doi:10.1021/bi981027m · Cited by 55
GRAHAM, A., Wakamatsu, K., HUNT, G., Ito, S., & Thody, A. J. (1997) · Pigment Cell Research · doi:10.1111/j.1600-0749.1997.tb00689.x · Cited by 53
Agouti Protein Inhibits Growth of B16 Melanoma Cellsin Vitroby Acting through Melanocortin Receptors
Siegrist, W., Willard, D. H., Wilkison, W. O., & Eberlé, A. N. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0030 · Cited by 50
AGOUTI PROTEIN CAN ACT INDEPENDENTLY OF MELANOCYTE-STIMULATING HORMONE TO INHIBIT MELANOGENESIS
HUNT, G., & Thody, A. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.147r001 · Cited by 47
B16‐G4F mouse melanoma cells: An MSH receptor‐deficient cell clone
Solca, F., Chluba, J., Iwata, K., & Eberlé, A. N. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81563-f · Cited by 33
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Seifert, R., & Wenzel-Seifert, K. (2002) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-002-0588-0 · Cited by 637
The Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
Tao, Y.-X. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0037 · Cited by 531
High constitutive signaling of the ghrelin receptor–identification of a potent inverse agonist
Holst, B., Cygankiewicz, A., Jensen, T. H., Ankersen, M., & Schwartz, T. W. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0069 · Cited by 515
Gantz, I., & Fong, T. M. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00434.2002 · Cited by 466
Metadata
- Authors
- Nijenhuis, W. A. J.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2001-01-01
- Volume
- 15
- Issue
- 1
- Pages
- 164-171
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W2059553252
- Cited by
- 406
- References
- 44
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.